Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07017439 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Investigating the Adjunctive Use of Mirabegron in the Early Post-Rezum Procedure Period

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 12, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The investigators propose conducting a randomized controlled trial at the Men's Health Clinic to evaluate whether patients who start and continue mirabegron postoperatively after undergoing Rezum therapy experience enhanced patient-reported outcomes, improved quality of life (QoL), and comparable rates of adverse events. There are no predicted adverse events of this study. There are no identified potential harms of this study.
Trial Details
NCT Number NCT07017439
Lead Sponsor University of Manitoba
Conditions
(from sponsor)		 Benign Prostate Hypertrophy(BPH)
Related terms Prostatic Hyperplasia
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov